The Optispan Podcast with Matt Kaeberlein cover image

We'll Pay $101 Million If You Prove You Can Reverse Aging

The Optispan Podcast with Matt Kaeberlein

00:00

Why was metformin chosen for TAME?

Jamie explains metformin's appeal: extensive human data, safety record, generic availability, and feasibility for an initial geroscience trial.

Play episode from 55:44
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app